{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:06:05Z","timestamp":1787169965855,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Idiopathic hypogonadotropic hypogonadism (IHH) is a form of male infertility caused by a congenital defect in the secretion or action of gonadotropin-releasing hormone from the hypothalamus. Oestradiol emerged as the main sex steroid in the regulation of the hypothalamic\u2013pituitary\u2013testicular axis, reproductive function and growth hormone\/insulin-like growth factor-1 (GH\/IGF-1) axis in men. Moreover, GH\/IGF-1 axis has been suggested to play a role in IHH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study evaluated serum IGF-1 in IHH men and controls. Furthermore, we evaluated the association between serum total oestradiol (TE2) and IGF-1 levels in patients and controls. Parameters including age, body mass index and fertility history were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This prospective study was conducted at the Royan institute.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In 20 men with IHH and 20 controls, serum IGF-1 levels were estimated using chemiluminescence immunoassay and serum E2 levels were assessed by means of the electrochemiluminescence method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Kolmogorov-Smirnov test, parametric t-test or the Mann-Whitney and the Pearson correlation coefficient were performed. SPSS version 22 was used for the analysis of data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was a significant decrease in serum IGF-1 levels in IHH patients compared with controls (145.1 \u00b1 8.9 ng\/ml vs. 229.6 \u00b1 7.3 ng\/ml\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001, respectively). Furthermore, a significant decrease was observed in TE2 levels in IHH male patients (12.3 \u00b1 2.5 pg\/ml) compared with controls (31.9 \u00b1 5.3 pg\/ml\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). A positive correlation was observed between serum IGF-1 and TE2 levels in the total number of participants, suggesting that E2 deficiency in IHH cases can explain the lower levels of serum IGF-1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings suggest that the reduction in IGF-1 levels may be associated with the influence of E2 on the GH\/IGF-1 axis, and may confirm the role of the GH\/IGF-1 axis in IHH. Further investigations will be required to determine the exact mechanisms by which E2 and IGF-1 affect the reproductive neuroendocrine function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_132_22","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T05:57:35Z","timestamp":1681538255000},"page":"351-356","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Male Idiopathic Hypogonadotropic Hypogonadism"],"prefix":"10.4103","volume":"15","author":[{"given":"Nastaran","family":"Salehisedeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Parhizkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehreh","family":"Yaghmaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Sabbaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240905","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2009.177","article-title":"The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism","volume":"5","author":"Bianco","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"R2-5-20240905","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/jim-2019-001233","article-title":"Male hypogonadism: A review","volume":"68","author":"Marcelli","year":"2020","journal-title":"J Investig Med"},{"key":"R3-5-20240905","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cnur.2018.04.006","article-title":"Male and female hypogonadism","volume":"53","author":"Richard-Eaglin","year":"2018","journal-title":"Nurs Clin North Am"},{"key":"R4-5-20240905","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet"},{"key":"R5-5-20240905","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2017.10.012","article-title":"Kallmann syndrome: Phenotype and genotype of hypogonadotropic hypogonadism","volume":"86","author":"Stamou","year":"2018","journal-title":"Metabolism"},{"key":"R6-5-20240905","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jfma.2021.03.010","article-title":"Clinical and molecular features of idiopathic hypogonadotropic hypogonadism in Taiwan: A single center experience","volume":"121","author":"Cho","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"R7-5-20240905","first-page":"113","article-title":"Update on the genetics of idiopathic hypogonadotropic hypogonadism","volume":"9","author":"Topalo\u011flu","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R8-5-20240905","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/endo.139.3.5852","article-title":"Insulin-like growth factor-I effects on gonadotropin-releasing hormone biosynthesis in GT1-7 cells","volume":"139","author":"Longo","year":"1998","journal-title":"Endocrinology"},{"key":"R9-5-20240905","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1210\/mend.11.8.9956","article-title":"Regulation of gonadotropin-releasing hormone (GnRH) gene expression by insulin-like growth factor I in a cultured GnRH-expressing neuronal cell line","volume":"11","author":"Zhen","year":"1997","journal-title":"Mol Endocrinol"},{"key":"R10-5-20240905","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000054496","article-title":"The insulin-like growth factor system in the GT1-7 GnRH neuronal cell line","volume":"70","author":"Anderson","year":"1999","journal-title":"Neuroendocrinology"},{"key":"R11-5-20240905","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/ijms22052445","article-title":"Anti-M\u00fcllerian hormone, growth hormone, and insulin-like growth factor 1 modulate the migratory and secretory patterns of GnRH neurons","volume":"22","author":"Cannarella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R12-5-20240905","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/EJE-18-1000","article-title":"Mechanisms in endocrinology: Estradiol as a male hormone","volume":"181","author":"Russell","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"R13-5-20240905","first-page":"66","article-title":"The role of estrogen modulators in male hypogonadism and infertility","volume":"18","author":"Rambhatla","year":"2016","journal-title":"Rev Urol"},{"key":"R14-5-20240905","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jcem-73-3-621","article-title":"Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men","volume":"73","author":"Finkelstein","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-5-20240905","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/eje.1.02254","article-title":"Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: Evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback","volume":"155","author":"Rochira","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R16-5-20240905","first-page":"3027","article-title":"Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback","volume":"85","author":"Hayes","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-5-20240905","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/jc.2007-2156","article-title":"Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: Evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men","volume":"93","author":"Pitteloud","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-5-20240905","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/en.2012-1045","article-title":"Arcuate kisspeptin\/neurokinin B\/dynorphin (KNDy) neurons mediate the estrogen suppression of gonadotropin secretion and body weight","volume":"153","author":"Mittelman-Smith","year":"2012","journal-title":"Endocrinology"},{"key":"R19-5-20240905","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2006-2819","article-title":"Gonadotropin-releasing hormone neurons express estrogen receptor-beta","volume":"92","author":"Hrabovszky","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-5-20240905","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/j.1743-6109.2010.02143.x","article-title":"Impact of long-term gonadotropin replacement treatment on sleep in men with idiopathic hypogonadotropic hypogonadism","volume":"8","author":"Ismailogullari","year":"2011","journal-title":"J Sex Med"},{"key":"R21-5-20240905","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/jcem-64-4-651","article-title":"Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism","volume":"64","author":"Liu","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-5-20240905","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R23-5-20240905","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3803\/EnM.2020.732","article-title":"Establishment of reference intervals for serum insulin-like growth factor I in Korean adult population","volume":"35","author":"Kim","year":"2020","journal-title":"Endocrinol Metab (Seoul"},{"key":"R24-5-20240905","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11102-007-0035-9","article-title":"Normal levels of serum IGF-I: Determinants and validity of current reference ranges","volume":"10","author":"Brabant","year":"2007","journal-title":"Pituitary"},{"key":"R25-5-20240905","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/CCLM.2010.009","article-title":"Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the immulite 2500: Results of the study of health in pomerania (SHIP)","volume":"48","author":"Friedrich","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R26-5-20240905","first-page":"521","article-title":"Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): Pathophysiological and genetic considerations","volume":"19","author":"Seminara","year":"1998","journal-title":"Endocr Rev"},{"key":"R27-5-20240905","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.fertnstert.2018.04.010","article-title":"Mutation profiles and clinical characteristics of Chinese males with isolated hypogonadotropic hypogonadism","volume":"110","author":"Zhou","year":"2018","journal-title":"Fertil Steril"},{"key":"R28-5-20240905","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1210\/jc.2018-01832","article-title":"Effect of testosterone on FGF2, MRF4, and myostatin in hypogonadotropic hypogonadism: Relevance to muscle growth","volume":"104","author":"Ghanim","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-5-20240905","first-page":"1407","article-title":"Activation of the somatotropic axis by testosterone in adult males: Evidence for the role of aromatization","volume":"76","author":"Weissberger","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-5-20240905","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000071310","article-title":"Activation of the somatotropic axis by testosterone in adult men: Evidence for a role of hypothalamic growth hormone-releasing hormone","volume":"77","author":"Bondanelli","year":"2003","journal-title":"Neuroendocrinology"},{"key":"R31-5-20240905","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.fertnstert.2011.03.091","article-title":"Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment","volume":"95","author":"Trabado","year":"2011","journal-title":"Fertil Steril"},{"key":"R32-5-20240905","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI112673","article-title":"Testosterone and estradiol are co-secreted episodically by the human testis","volume":"78","author":"Winters","year":"1986","journal-title":"J Clin Invest"},{"key":"R33-5-20240905","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1210\/jcem.85.9.6811","article-title":"Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: Study of Sertoli and Leydig cell secretions and interactions","volume":"85","author":"Young","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-5-20240905","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/me.2013-1245","article-title":"Both estrogen receptor \u03b1 and \u03b2 stimulate pituitary GH gene expression","volume":"28","author":"Avtanski","year":"2014","journal-title":"Mol Endocrinol"},{"key":"R35-5-20240905","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/jc.2009-1743","article-title":"Tall stature without growth hormone: Four male patients with aromatase deficiency","volume":"95","author":"Rochira","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-5-20240905","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1210\/jc.2018-00755","article-title":"Aromatized estrogens amplify nocturnal growth hormone secretion in testosterone-replaced older hypogonadal men","volume":"103","author":"Roelfsema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-5-20240905","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fendo.2018.00660","article-title":"Hypothalamus-pituitary-adrenal dysfunction in cholestatic liver disease","volume":"9","author":"Petrescu","year":"2018","journal-title":"Front Endocrinol (Lausanne"},{"key":"R38-5-20240905","doi-asserted-by":"crossref","first-page":"630503","DOI":"10.3389\/fcell.2021.630503","article-title":"Growth hormone\/insulin growth factor axis in sex steroid associated disorders and related cancers","volume":"9","author":"Bleach","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R39-5-20240905","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/andr.12088","article-title":"Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism","volume":"3","author":"Rohayem","year":"2015","journal-title":"Andrology"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_132_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:15:41Z","timestamp":1787166941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_132_22"}},"subtitle":["Serum Insulin-like Growth Factor-1 and Oestradiol Levels"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_132_22","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}